Randomized Phase II Trial of Sulindac for Lung Cancer Chemoprevention

INTRODUCTION: Sulindac represents a promising candidate agent for lung cancer chemoprevention, but clinical trial data have not been previously reported. We conducted a randomized, phase II chemoprevention trial involving current or former cigarette smokers (≥ 30 pack-years) utilizing the multi-cent...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Limburg, Paul J., Mandrekar, Sumithra J., Aubry, Marie Christine, Ziegler, Katie L. Allen, Zhang, Jun, Yi, Joanne E., Henry, Michael, Tazelaar, Henry D., Lam, Stephen, McWilliams, Annette, Midthun, David E., Edell, Eric S., Rickman, Otis B., Mazzone, Peter, Tockman, Melvyn, Beamis, John F., Lamb, Carla, Simoff, Michael, Loprinzi, Charles, Szabo, Eva, Jett, James
格式: Artigo
語言:Inglês
出版: 2012
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566344/
https://ncbi.nlm.nih.gov/pubmed/23261228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2012.11.011
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍